当前位置: X-MOL 学术Eur. J. Pharm. Biopharm. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Phosphorylated PEG-emulsifier: Powerful tool for development of zeta potential changing self-emulsifying drug delivery systems (SEDDS)
European Journal of Pharmaceutics and Biopharmaceutics ( IF 4.9 ) Pub Date : 2020-03-06 , DOI: 10.1016/j.ejpb.2020.03.004
Julian Dominik Wolf , Markus Kurpiers , Roman Xaver Götz , Sergey Zaichik , Andrea Hupfauf , Daniel Baecker , Ronald Gust , Andreas Bernkop-Schnürch

Aim

It was the aim of this study to synthesize a phosphorylated emulsifier possessing a PEG-linker for establishment of a potent zeta potential changing system in self-emulsifying drug delivery systems (SEDDS).

Methods

N,N'–Bis(polyoxyethylene)oleylamine (POA) was phosphorylated utilizing pyrophosphoric acid. Successful synthesis of POA bisphosphate (POAP) was confirmed by NMR and HR CS MAS. After incorporation of 1% POAP into SEDDS (Kolliphor RH 40, Capmul PG-8, Labrafac Lipophile WL 1349, Labrafac PG; 30/20/20/30, v/v), according emulsions were incubated with intestinal alkaline phosphatase (IAP) and the zeta potential was measured. Additionally, the amount of released phosphate upon incubation with IAP or on Caco-2 cells was quantified by malachite green assay. Finally, cell viability studies on Caco-2 cells were performed and mucus permeation properties with and without IAP preincubation were assessed.

Results

POAP was synthesized as brown viscous liquid with a yield of 36% and could be incorporated into SEDDS. By incubation with IAP a zeta potential shift from -15.1 to 6.5 mV was observed. A corresponding phosphate release in presence of isolated IAP as well as on Caco-2 cells was found. Assessment of the cytotoxic potential revealed no significant alteration in the safety profile of SEDDS by incorporation of POAP. Mucus permeation studies exposed a 2-fold higher permeation of fluorescein diacetate (FDA) having been embedded in SEDDS loaded with POAP in comparison to blank formulation and 3-fold higher permeability than for emulsions having been preincubated with phosphatase.

Conclusion

The novel phosphorylated surfactant exhibiting a PEG-linker facilitated a potent zeta potential change of SEDDS.



中文翻译:

磷酸化PEG乳化剂:强大的工具,可开发zeta电位变化型自乳化药物递送系统(SEDDS)

目标

这项研究的目的是合成具有PEG接头的磷酸化乳化剂,以在自乳化药物递送系统(SEDDS)中建立有效的ζ电势改变系统。

方法

N,N'-双(聚氧乙烯)油胺(POA)被焦磷酸磷酸化。NMR和HR CS MAS证实了POA双磷酸酯(POAP)的成功合成。将1%POAP掺入SEDDS(Kolliphor RH 40,Capmul PG-8,Labrafac Lipophile WL 1349,Labrafac PG; 30/20/20/30,v / v)中后,将乳化液与肠碱性磷酸酶(IAP)一起孵育并测量了ζ电势。另外,通过孔雀石绿分析定量与IAP一起孵育或在Caco-2细胞上释放的磷酸盐的量。最后,对Caco-2细胞进行了细胞活力研究,并评估了有无IAP预温育的粘液渗透特性。

结果

POAP合成为棕色粘稠液体,产率为36%,可以掺入SEDDS中。通过与IAP孵育,观察到ζ电位从-15.1变为6.5 mV。发现在分离的IAP存在下以及在Caco-2细胞上相应的磷酸盐释放。对细胞毒性潜力的评估表明,通过掺入POAP,SEDDS的安全性没有明显改变。粘液渗透研究表明,与空白制剂相比,已嵌入装有POAP的SEDDS中的二乙酸荧光素(FDA)渗透率高2倍,而渗透率则比用磷酸酶预孵育的乳液高3倍。

结论

表现出PEG接头的新型磷酸化表面活性剂促进了SEDDS的有效Zeta电位变化。

更新日期:2020-03-06
down
wechat
bug